Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.66 USD | +3.29% | -6.56% | +0.23% |
May. 08 | Syndax Pharmaceuticals Q1 Net Loss Widens | MT |
May. 08 | Transcript : Syndax Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Financials (USD)
Sales 2024 * | 31.52M | Sales 2025 * | 108M | Capitalization | 1.84B |
---|---|---|---|---|---|
Net income 2024 * | -307M | Net income 2025 * | -270M | EV / Sales 2024 * | 57.9 x |
Net cash position 2024 * | 15.24M | Net cash position 2025 * | 171M | EV / Sales 2025 * | 15.5 x |
P/E ratio 2024 * |
-6.07
x | P/E ratio 2025 * |
-7.35
x | Employees | 184 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.15% |
Latest transcript on Syndax Pharmaceuticals, Inc.
1 day | +3.29% | ||
1 week | -6.56% | ||
Current month | +2.51% | ||
1 month | -0.28% | ||
3 months | -1.50% | ||
6 months | +47.35% | ||
Current year | +0.23% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Metzger
CEO | Chief Executive Officer | 53 | 15-05-04 |
Peter Ordentlich
FOU | Founder | 55 | 05-10-10 |
Neil Gallagher
PSD | President | 60 | 23-04-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 17-03-28 |
Dennis Podlesak
CHM | Chairman | 66 | 08-11-30 |
Pierre Legault
BRD | Director/Board Member | 63 | 17-01-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.12% | 0 M€ | 0.00% | - | |
0.12% | 0 M€ | 0.00% | - | |
0.08% | 2 M€ | -.--% | ||
0.06% | 1,487 M€ | +7.21% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 21.66 | +3.29% | 981,647 |
24-05-13 | 20.97 | -3.59% | 1,271,693 |
24-05-10 | 21.75 | -1.00% | 649,872 |
24-05-09 | 21.97 | -1.83% | 838,175 |
24-05-08 | 22.38 | -3.45% | 1,105,810 |
Delayed Quote Nasdaq, May 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.23% | 1.84B | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+47.07% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- SNDX Stock